Funding news
Imperagen logo

Imperagen Secures $6.4M

Recently funded · $6.4M SeedTechnology, Information and MediaView source

Get the full Imperagen company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Enzyme engineering startup Imperagen, which uses an AI-driven platform to develop high-performance enzymes, has closed a $6.4M seed funding round. The company aims to help clients improve production processes while reducing cost, time, and environmental impact.

Founded by researchers from the Manchester Institute of Biotechnology, Imperagen's integrated platform combines advanced computational modeling with automated lab testing. This closed-loop system continuously learns from real-world data, allowing for more accurate and efficient enzyme design, testing, and refinement for clients in pharma, life sciences, chemicals, and consumer goods.

Other recently funded companies

View all

Biggest recent AI rounds

Largest funding rounds in AI on Signalbase right now.

#CompanyAmount
1
Nuance Healthcare logo

Nuance Healthcare

United States

$19.7B
2
OpenAI logo

OpenAI

United States

$13.0B
3
Anthropic logo

Anthropic

United States

$13.0B
4
AIMAX logo

AIMAX

United Kingdom

$10.0B
5
Preferred Networks, Inc. logo

Preferred Networks, Inc.

Japan

¥10.0B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Texas Automated Robotics Systems, LLC logo

Texas Automated Robotics Systems, LLC

United States

$513.0M
2
Viseur AI - Digital Pathology Platform logo

Viseur AI - Digital Pathology Platform

Turkey

$350.0K
3
Coachbetter logo

Coachbetter

Switzerland

$8.2M
4
Forus logo

Forus

France

$6.0M
5
GENI logo

GENI

$8.0M